AFJK | Aimei Health Technology Co., Ltd Ordinary Share

Annual Income Statements

(In USD)

Breakdown	2023
Revenue	-
Cost of Revenue	-
Gross Profit	-
Operating Expenses	28.45 Thousand
Selling, General and Administrative Expenses	28.45 Thousand
Research and Development Expenses	-
Other Expenses	-
Cost and Expenses	28.45 Thousand
Operating Income	-28.46 Thousand
Interest Expense	-
Income Tax Expense	171.38 Thousand
Earnings before Tax	171.38 Thousand
Net Income	171.38 Thousand
Earnings Per Share Basic	0.02
Earnings Per Share Diluted	0.02
Weighted Average Shares Outstanding	9.02 Million
Weighted Average Shares Outstanding (Diluted)	9.02 Million
Gross Margin	-
EBIT Margin	-
Profit Margin	-
EBITDA	171.38 Thousand
Earnings Before Tax Margin	-

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Revenue	-	-	-	-	-
Cost of Revenue	309.11 Thousand	153.63 Thousand	-	-	-
Gross Profit	-309.11 Thousand	-153.63 Thousand	-	-	-
Operating Expenses	309.11 Thousand	153.63 Thousand	28.45 Thousand	24.84 Thousand	-
Selling, General and Administrative Expenses	309.11 Thousand	153.63 Thousand	-	24.84 Thousand	-
Research and Development Expenses	-	-	-	-	-
Other Expenses	309.11 Thousand	-	-	-	-
Cost and Expenses	309.11 Thousand	153.63 Thousand	28.45 Thousand	24.84 Thousand	-
Operating Income	-309.11 Thousand	-153.63 Thousand	-28.46 Thousand	-24.84 Thousand	-
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Earnings before Tax	609.09 Thousand	755.5 Thousand	171.38 Thousand	175 Thousand	-
Net Income	609.09 Thousand	755.5 Thousand	171.38 Thousand	175 Thousand	-
Earnings Per Share Basic	0.07	0.08	-	0.02	-
Earnings Per Share Diluted	0.07	0.08	-	0.02	-
Weighted Average Shares Outstanding	9.02 Million	9.02 Million	9.02 Million	9.02 Million	7.86 Million
Weighted Average Shares Outstanding (Diluted)	9.02 Million	9.02 Million	9.02 Million	9.02 Million	7.86 Million
Gross Margin	-	-	-	-	-
EBIT Margin	-	-	-	-	-
Profit Margin	-	-	-	-	-
EBITDA	-309.11 Thousand	-153.63 Thousand	-	-24.84 Thousand	-
Earnings Before Tax Margin	-	-	-	-	-